Abstract
Stroke is one of the leading causes of mortality worldwide. Stroke can either be haemorrhagic (13%) or ischaemic (87%) in nature. Within the first few days of stroke, transient ischaemic attacks may occur and will require urgent intervention. However, this is often missed by healthcare workers. This article outlines the current evidence-based practice for stroke management and care. Based on the aetiology, this may include early reperfusion with a tissue plasminogen activator (t-PA), antiplatelet therapy and warfarin. This paper outlines many of the recommendations of the published National Clinical Guidelines for Stroke. It also covers aspects of multidisciplinary stroke care, from initial assessment and acute treatment, to rehabilitation strategies and the management of complications.
| Original language | English |
|---|---|
| Pages (from-to) | 26-34 |
| Number of pages | 9 |
| Journal | SA Pharmaceutical Journal |
| Volume | 87 |
| Issue number | 4 |
| Publication status | Published - 1 Jan 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Haemorrhagic stroke
- Hypertension
- Ischaemic stroke
- Reperfusion
- Stroke
- Tissue plasminogen activator
Fingerprint
Dive into the research topics of 'An updated guide to treating stroke'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver